Pharmacy Face-Off: Rite Aid, Walgreen, or CVS

Rite Aid , Walgreen & Co , and CVS Corp  are the largest pharmacy operators in the United States. The three are responsible for filling more than a third of the $276 billion worth of prescriptions ordered by doctors in 2012.
Since millions of Americans are newly insured under health care reform, spending on prescription drugs may climb as much as 9% this year, creating a massive opportunity for Rite Aid, Walgreen, and CVS to capture market share.  
In the following slideshow, you'll see which of these companies may have the best chance of capitalizing on this growth opportunity and rewarding investors with shareholder-friendly profit. 

Six stock picks poised for incredible growth
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently, one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his six carefully chosen picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.


The article Pharmacy Face-Off: Rite Aid, Walgreen, or CVS originally appeared on

Todd Campbell has no position in any stocks mentioned. Todd owns E. B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool recommends CVS Caremark. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.